001     120146
005     20240303002316.0
024 7 _ |a 10.4161/epi.29941
|2 doi
024 7 _ |a pmid:25147919
|2 pmid
024 7 _ |a pmc:PMC4169017
|2 pmc
024 7 _ |a 1559-2294
|2 ISSN
024 7 _ |a 1559-2308
|2 ISSN
024 7 _ |a altmetric:2628597
|2 altmetric
037 _ _ |a DKFZ-2017-00729
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Poetsch, Anna R
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia.
260 _ _ |a Austin, Tex.
|c 2014
|b Landes Bioscience
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1490967423_3742
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Aberrant DNA methylation at specific genetic loci is a key molecular feature of juvenile myelomonocytic leukemia (JMML) with poor prognosis. Using quantitative high-resolution mass spectrometry, we identified RASA4 isoform 2, which maps to chromosome 7 and encodes a member of the GAP1 family of GTPase-activating proteins for small G proteins, as a recurrent target of isoform-specific DNA hypermethylation in JMML (51% of 125 patients analyzed). RASA4 isoform 2 promoter methylation correlated with clinical parameters predicting poor prognosis (older age, elevated fetal hemoglobin), with higher risk of relapse after hematopoietic stem cell transplantation, and with PTPN11 mutation. The level of isoform 2 methylation increased in relapsed cases after transplantation. Interestingly, most JMML cases with monosomy 7 exhibited hypermethylation on the remaining RASA4 allele. The results corroborate the significance of epigenetic modifications in the phenotype of aggressive JMML.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Protein Isoforms
|2 NLM Chemicals
650 _ 7 |a RASA4 protein, human
|2 NLM Chemicals
650 _ 7 |a ras GTPase-Activating Proteins
|2 NLM Chemicals
650 _ 7 |a PTPN11 protein, human
|0 EC 3.1.3.48
|2 NLM Chemicals
650 _ 7 |a Protein Tyrosine Phosphatase, Non-Receptor Type 11
|0 EC 3.1.3.48
|2 NLM Chemicals
700 1 _ |a Lipka, Daniel
|0 P:(DE-He78)c403a040c97f91902a7d31b93859f9fc
|b 1
|u dkfz
700 1 _ |a Witte, Tania
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Claus, Rainer
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Nöllke, Peter
|b 4
700 1 _ |a Zucknick, Manuela
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Olk-Batz, Christiane
|b 6
700 1 _ |a Fluhr, Silvia
|b 7
700 1 _ |a Dworzak, Michael
|b 8
700 1 _ |a De Moerloose, Barbara
|b 9
700 1 _ |a Starý, Jan
|b 10
700 1 _ |a Zecca, Marco
|b 11
700 1 _ |a Hasle, Henrik
|b 12
700 1 _ |a Schmugge, Markus
|b 13
700 1 _ |a van den Heuvel-Eibrink, Marry M
|b 14
700 1 _ |a Locatelli, Franco
|b 15
700 1 _ |a Niemeyer, Charlotte M
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Flotho, Christian
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Plass, Christoph
|0 P:(DE-He78)4301875630bc997edf491c694ae1f8a9
|b 18
|e Last author
|u dkfz
773 _ _ |a 10.4161/epi.29941
|g Vol. 9, no. 9, p. 1252 - 1260
|0 PERI:(DE-600)2248598-3
|n 9
|p 1252 - 1260
|t Epigenetics
|v 9
|y 2014
|x 1559-2308
909 C O |o oai:inrepo02.dkfz.de:120146
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)c403a040c97f91902a7d31b93859f9fc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)4301875630bc997edf491c694ae1f8a9
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2014
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EPIGENETICS-US : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C010-20160331
|k C010
|l Epigenomik und Krebsrisikofaktoren
|x 0
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 1
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 2
920 1 _ |0 I:(DE-He78)L601-20160331
|k L601
|l DKTK Freiburg
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C010-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a I:(DE-He78)L601-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21